Nuclear receptors regulate the transcription of genes and various functions such as development, differentiation, homeostasis, and behavior by formation of complexes with ligand and co-activator. Recent findings have shown that agonists of a ligand may have a toxic effect on cellular/tissular function through improper activation of nuclear receptors. In this study, a simple assay system of hetero-complexes of three different molecules (estrogen receptor, ligand, and co-activator peptide) has been developed. This assay system employs functionalized gold nanoparticles (GNPs: 15 nm in diameter). The surfaces of the GNPs were modified by a 12- or 20-amino-acid peptide that contains the sequence of co-activator for activating nuclear receptor by an agonist ligand. Owing to the affinity of the peptide, the functionalized GNPs aggregate faster when the nuclear receptor and the agonist ligand are also present. The aggregation of GNPs can be identified by shifts in adsorption spectrum, which give information about the specificity of agonist ligands. Similarly, this spectrum shift can measure concentration of known agonist ligand. This simple agonist screening will be employed as high through-put analysis (HTA) in the discovery of drugs that act through nuclear receptors.
References
[1]
Drews, J. Drug discovery: A historical perspective. Science 2000, 287, 1960–1964.
[2]
Aranda, A.; Pascual, A. Nuclear hormone receptors and gene expression. Phys. Rev. 2001, 81, 1269–1304.
[3]
Chawla, A.; Repa, J.J.; Evans, R.M.; Mangelsdorf, D.J. Nuclear receptors and lipid physiology: Opening the X-files. Science 2001, 294, 1866–1870.
[4]
Gupta, N.; Ragsdale, S.W. Thiol-disulfide redox dependence of heme binding and heme ligand switching in nuclear hormone receptor rev-erb{beta}. J. Biol. Chem. 2011, 286, 4392–403.
[5]
Staudinger, J.L.; Lichti, K. Cell signaling and nuclear receptors: New opportunities for molecular pharmaceuticals in liver disease. Mol. Pharm. 2008, 5, 17–34.
[6]
Christakos, S.; Dhawan, P.; Liu, Y.; Peng, X.R.; Porta, A. New insights into the mechanisms of vitamin D action. J. Cell. BioChem. 2003, 88, 695–705.
[7]
Panigrahy, D.; Kaipainen, A.; Huang, S.; Butterfield, C.E.; Barnes, C.M.; Fannon, M.; Laforme, A.M.; Chaponis, D.M.; Folkman, J.; Kieran, M.W. PPAR alpha agonist fenofibrate suppresses tumor growth through direct and indirect angiogenesis inhibition. Proc. Natl. Acad. Sci. USA 2008, 105, 985–990.
[8]
Yki-Jarvinen, H. Thiazolidinediones. N. Engl. J. Med. 2004, 351, 1106–1118.
[9]
Moore, L.B.; Goodwin, B.; Jones, S.A.; Wisely, G.B.; Serabjit-Singh, C.J.; Willson, T.M.; Collins, J.L.; Kliewer, S.A. St. John's wort induces hepatic drug metabolism through activation of the pregnane X receptor. Proc. Natl. Acad. Sci. USA 2000, 97, 7500–7502.
[10]
Habauzit, D.; Armengaud, J.; Roig, B.; Chopineau, J. Determination of estrogen presence in water by SPR using estrogen receptor dimerization. Anal. Bioanal. Chem. 2008, 390, 873–883.
[11]
Carmon, K.S.; Baltus, R.E.; Luck, L.A. A biosensor for estrogenic substances using the quartz crystal microbalance. Anal. BioChem. 2005, 345, 277–283.
[12]
Camp, H.S.; Tafuri, S.R. Regulation of peroxisome proliferator-activated receptor gamma activity by mitogen-activated protein kinase. J. Biol. Chem. 1997, 272, 10811–10816.
[13]
Dissanayake, N.; Levy, M.; Chakravarty, A.; Heiden, P.A.; Chen, N.; Fratello, V.J. Magneto-photonic crystal optical sensors with sensitive covers. Appl. Phys. Lett. 2011, doi:10.1063/1.3633344..
[14]
Si, S.; Kotal, A.; Mandal, T.K. One-dimensional assembly of peptide-functionalized gold nanoparticles: An approach toward mercury ion sensing. J. Phys. Chem. C 2007, 111, 1248–1255.
[15]
Sato, K.; Hosokawa, K.; Maeda, M. Colorimetric biosensors based on DNA-nanoparticle conjugates. Anal. Sci. 2007, 23, 17–20.
[16]
Endo, T.; Kerman, K.; Nagatani, N.; Hiepa, H.M.; Kim, D. K.; Yonezawa, Y.; Nakano, K.; Tamiya, E. Multiple label-free detection of antigen-antibody reaction using localized surface plasmon resonance-based core-shell structured nanoparticle layer nanochip. Anal. Chem. 2006, 78, 6465–6475.
[17]
Ishida, T.; Kuroda, K.; Kinoshita, N.; Minagawa, W.; Haruta, M. Direct deposition of gold nanoparticles onto polymer beads and glucose oxidation with H2O2. J. Colloid. Interf. Sci. 2008, 323, 105–111.
[18]
Bramlett, K.S.; Burris, T.P. Effects of selective estrogen receptor modulators (SERMs) on coactivator nuclear receptor (NR) box binding to estrogen receptors. Mol. Genet. Metab. 2002, 76, 225–33.
[19]
Sakamoto, H.; Ikeno, S.; Kato, T.; Nishino, N.; Haruyama, T. Smart immobilization of oligopeptides through electrochemical deposition onto surface. Anal. Chim. Acta. 2007, 604, 76–80.
[20]
Ma, H.; Chung, M.H.; Lu, Y.; Nishihara, T.; Hattori, M. Estrogenic Effects of the Herbal formula, Menoprogen, in Ovariectomized Rats. Biol. Pharm. Bull. 2010, 33, 455–460.
[21]
Levy, R.; Thanh, N.T.K.; Doty, R.C.; Hussain, I.; Nichols, R.J.; Schiffrin, D.J.; Brust, M.; Fernig, D.G. Rational and combinatorial design of peptide capping Ligands for gold nanoparticles. J. Am. Chem. Soc. 2004, 126, 10076–10084.
